Escitalopram in the treatment of patients with agitated dementia.
Phase of Trial: Phase IV
Latest Information Update: 23 Feb 2012
At a glance
- Drugs Escitalopram (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 23 Feb 2012 Actual end date (Dec 2006) added as reported by ClinicalTrials.gov.
- 23 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Sep 2006 New trial record.